Answers are grounded in this paper and cite their sources.
Myelodysplastic syndromes occur mainly in older persons, and these patients are likely to have comorbidities that significantly worsen their survival. In this perspective article, Drs. Della Porta and Malcovati examine the relevance of comorbidities for clinical decision making in patients with myelodysplasti syndromes.
No takes yet. Share an insight, caveat, or question.
Porta et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: